IDENTIFICATION OF NEOANTIGENS

SERVICE PROFILE

Analyses of WES and transcriptome data of tumor tissue or CTCs and matched PBMCs, a source of normal germline DNA, from a cancer patient by advanced bioinformatics algorithms are used to identify the specific coding or non-coding sequence mutations, from which neoantigen, a class of HLA-bound peptides, arise.